Raymond James Financial, Inc. Common Stock (NY:RJF)

158.21 -1.55 (-0.97%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Raymond James Financial, Inc. Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

35 36 Next >

Raymond James Financial Reports Fiscal Second Quarter of 2024 Results

April 24, 2024

From Raymond James Financial

Via GlobeNewswire

(RJF) - Analyzing Raymond James Finl's Short Interest ↗

April 17, 2024

Via Benzinga

Raymond James Just Raised Its Price Target on Nvidia (NVDA) Stock ↗

April 11, 2024

Nvidia stock is on the move Thursday after shares of NVDA got an increased price target of $1,100 from Raymond James analysts.

Via InvestorPlace

Deep Dive Into Raymond James Finl Stock: Analyst Perspectives (4 Ratings) ↗

April 09, 2024

Via Benzinga

Alpha Fit Club Headlines Red Bank Classic 5K Set for June 15

April 08, 2024

Business Community Gears Up for Fifth Edition of Charity Run/Walk Supporting Water Safety Education for Borough YouthRED BANK, N.J. - April 8, 2024 - PRLog -- Red Bank RiverCenter is pleased to...

Via PRLog

Is Estée Lauder on the Verge Of a Massive Comeback?

April 04, 2024

There has been a seemingly endless run of analyst upgrades of Estée Lauder stock in recent months, and it's effectively been all one-way traffic.

Via MarketBeat

If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,100 Today ↗

March 26, 2024

Via Benzinga

Evaluating Raymond James Finl: Insights From 8 Financial Analysts ↗

March 22, 2024

Via Benzinga

Peering Into Raymond James Finl's Recent Short Interest ↗

March 04, 2024

Via Benzinga

3 Companies Buying Back Stock Before New Highs

April 01, 2024

Three stocks that seemed cheap enough for insiders to buy are also calling Wall Street analysts attention for potentially higher prices in the coming months

Via MarketBeat

Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says ↗

March 28, 2024

Raymond James resumes coverage of Amgen highlighting its diversified portfolio and strong presence across therapeutic areas for sustainable long-term growth. Innovative pipeline in oncology, rare...

Via Benzinga

The Dividend Dream Team: 3 Stocks Delivering Dependable Payouts ↗

March 27, 2024

Dividend stocks PepsiCo, Starbucks, and ONEOK are ideal for investors seeking dependable payouts in a volatile market environment.

Via InvestorPlace

Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In' ↗

March 25, 2024

Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to Jim Cramer.

Via Benzinga

Raymond James Financial Inc. (NYSE: RJF) Highlighted for Surprising Price Action

March 21, 2024

Via Investor Brand Network

Raymond James Financial Names Paul Shoukry President and CEO Successor, Announces Additional Key Leadership Changes

March 19, 2024

From Raymond James Financial

Via GlobeNewswire

Reflections From The Middle Seat: An Allocators Journey To Private Capital Advisory ↗

March 19, 2024

I left a limited partner seat in April 2022 to join the Private Capital Advisory team at Raymond James and have received many questions weekly since from both LPs and General Partners.

Via Talk Markets

Best Stocks To Watch This Week - Sunday, March 17 ↗

March 17, 2024

In this video, I review the week's trading and discuss which stocks would be the best to keep an eye on as we move into the new week of trading.

Via Talk Markets

Raymond James Maintains Outperform Rating for Host Hotels & Resorts: Here's What You Need To Know ↗

March 15, 2024

Via Benzinga

Raymond James Financial Declares Quarterly Dividends on Common and Preferred Stock

February 23, 2024

From Raymond James Financial

Via GlobeNewswire

Bears covered shorts on this ETF, 3 stocks to pop on the shift

February 21, 2024

Bears have ditched their short positions on this ETF, admitting that they too see a bull case for the economy, and these are the stocks to get paid first

Via MarketBeat

Topics Bonds ETFs Economy

Raymond James Is Souring on Carvana (CVNA) Stock ↗

February 16, 2024

Raymond James issued a "sell" rating on Carvana. Here’s why betting against CVNA stock is a complicated proposition.

Via InvestorPlace

Raymond James Maintains Strong Buy Rating for Patterson-UTI Energy: Here's What You Need To Know ↗

February 16, 2024

Via Benzinga

Stock Market Boom: Top 3 Financial Stocks to Ride the Rally ↗

February 13, 2024

The bull market will cause much more wealth to enter stocks, Here are three of the top names poised to benefit from a financial stocks boom.

Via InvestorPlace

This Analyst Downgrades Tractor Supply Despite EPS Beat, Cites Short-Term Hurdles ↗

February 02, 2024

Raymond James analyst Bobby Griffin downgrades Tractor Supply to Outperform, citing near-term earnings challenges post Q4 results. Despite a slight miss in sales and a beat in adjusted EPS, the analyst...

Via Benzinga

Why Snowflake Stock Is Trading At New 52-Week High ↗

February 02, 2024

Raymond James noted current public cloud trends as positive and specifically highlighted Amazon.com's fourth-quarter AWS revenue growth re-acceleration as favorable to Snowflake as its Cloud Data...

Via Benzinga

Fastly, General Mills And 2 Other Stocks Insiders Are Selling ↗

February 01, 2024

The Nasdaq 100 closed lower by more than 300 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Raymond James Maintains Strong Buy Rating for Marathon Petroleum: Here's What You Need To Know ↗

January 31, 2024

Via Benzinga

Yes, Colgate-Palmolive can clean its way to a fresh all-time high

January 30, 2024

Colgate-Palmolive is in an upswing driven by analysts' sentiment and results; it may experience a price-multiple expansion and hit new highs this year

Via MarketBeat

Colgate's Bright Smile: Analyst Envisions Upswing In 2024 Guidance With Ample Growth Opportunities ↗

January 29, 2024

Raymond James analyst upgrades Colgate-Palmolive to Outperform and announces $91 price target. Strong Q4 earnings and 2024 outlook cited.

Via Benzinga

Morgan Stanley Maintains Equal-Weight Rating for Raymond James Finl: Here's What You Need To Know ↗

January 29, 2024

Via Benzinga

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.